Patent details

EP2293076 Title: Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease

Basic Information

Publication number:
EP2293076
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101882892
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
French Title of Invention:
Procédé de stratification du risque chez des patients ayant une maladie primaire non infectieuse
German Title of Invention:
Verwendung von Procalcitonin zur Risikoeinteilung von Patienten mit einer primären, nicht-infektiösen Krankheit
SPC Number:

Dates

Filing date:
01/08/2008
Grant date:
19/12/2012
EP Publication Date:
19/12/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/03/2011
EP B1 Publication Date:
19/12/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/08/2013
Expiration date:
01/08/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/08/2008
 
 

Name:
B.R.A.H.M.S GmbH
Address:
Neuendorfstrasse 25, 16761 Hennigsdorf, Germany (DE)

Inventor

1

Name:
Struck Joachim
Address:
Germany (DE)

2

Name:
Bergmann Andreas
Address:
Germany (DE)

Priority

1

Priority Number:
07015271
Priority Date:
03/08/2007
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
08152651
Priority Date:
12/03/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
G01N 33/68;

Publication

European Patent Bulletin

Issue number:
202032
Publication date:
05/08/2020
Description:
Opposition rejected; Patent maintained as granted
Filing date Document type Number of pages